GGrantIndex
Sort

15,440 grants matching organoids

Cell Type and Regional Vulnerability in Frontotemporal Dementia

$663,462
Sally Temple · Regenerative Research Foundation · R01 · FY2024 · NS

Bronchiolitis Obliterans: Discovery and Therapy

$663,454
Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2023 · HL

Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoids

$663,363
Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2025 · CA

The Role of Renal Interstitium in Kidney Development

$663,312
Thomas Joseph Carroll · Ut Southwestern Medical Center · R01 · FY2024 · DK

Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome

$663,249
Steven M Finkbeiner · J. David Gladstone Institutes · R01 · FY2020 · AG

Thyroid Physiology Studies of Inherited Disorders

$663,166
Samuel Refetoff · University Of Chicago · R01 · FY2019 · DK

Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer

$663,143
Faraz Bishehsari · Rush University Medical Center · R01 · FY2022 · CA

The Human Distal Airway Aging Project

$663,011
Renat Shaykhiev · Weill Medical Coll Of Cornell Univ · U01 · FY2020 · HL

Sphingolipid Biosynthesis in the Healthy and Diseased Epidermal Barrier

$662,930
Brian W Wattenberg · Virginia Commonwealth University · R01 · FY2025 · AR

"DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer"

$662,893
David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Multiplexed drug testing of micro-dissected tumors using a microfluidic platform with integrated electrochemical aptasensors

$662,835
Albert Folch · University Of Washington · R01 · FY2025 · CA

Role of the TE-cGAS-STING pathway in C9orf72-ALS/FTD pathogenesis

$662,789
Davide Trotti · Thomas Jefferson University · R01 · FY2025 · NS

Multiscale analysis of metabolic inflammation as a driver of breast cancer

$662,592
Gerald V Denis · Boston University Medical Campus · U01 · FY2022 · CA

Understanding robust cellular information processing in complex environments and development of enabling single-cell analysis technologies

$662,582
Savas Tay · University Of Chicago · R35 · FY2023 · GM

Project 1: Targeting Oncogenic Transcription Factors

$662,404
Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2025 · CA

Project 1: Targeting Oncogenic Transcription Factors

$662,400
Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2023 · CA

Vascular networks genetically engineered for protein drug delivery

$662,263
Juan M Melero-Martin · Boston Children'S Hospital · R01 · FY2021 · HL

Gaining insight into psychiatric disease by engineering piece by piece the human brain in vitro.

$662,036
Sergiu Pasca · Stanford University · R01 · FY2024 · MH

Regenerative pathways in the avian cochlea

$661,892
Stefan Heller · Stanford University · R01 · FY2023 · DC

Cancer Immune-Interception for Lynch Syndrome

$661,865
Eduardo Vilar Sanchez · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Understanding renal intrinsic repair by FANCD2

$661,694
Ryuji Morizane · Massachusetts General Hospital · R01 · FY2025 · DK

Synthetic toolkit for precision gene expression control and signal processing in mammalian cells

$661,543
Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2021 · EB

Evaluating and Targeting RNA granules in neurodegenerative diseases

$661,492
Eugene Wei-Ming Yeo · University Of California, San Diego · R56 · FY2020 · AG

Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung

$661,391
Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA

Engineering Dual-Targeted Nanoplatforms to Effectively Treat NSCLC.

$661,001
Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2023 · EB